Investigating Celastrol’s Anti-DCM Targets and Mechanisms via Network Pharmacology and Experimental...
Investigating Celastrol’s Anti-DCM Targets and Mechanisms via Network Pharmacology and Experimental Validation
About this item
Full title
Author / Creator
Xi, Rui , Wan, Yongxin , Yang, Lihong , Zhang, Jingying , Yang, Liu , Yang, Shuai , Chai, Rui , Mu, Fengchen , Sun, Qiting , Yan, Rui , Wu, Zhifang and Li, Sijin
Publisher
United States: Hindawi
Journal title
Language
English
Formats
Publication information
Publisher
United States: Hindawi
Subjects
More information
Scope and Contents
Contents
Background and Purpose. DCM (diabetic cardiomyopathy), which may lead to significant complications including cardiovascular lesions, arrhythmia, and even heart failure, has a beginning element now known to be myocardial energy rebuilding. There are limited research on Celastrol’s ability to guard against this in the United States and elsewhere. Sin...
Alternative Titles
Full title
Investigating Celastrol’s Anti-DCM Targets and Mechanisms via Network Pharmacology and Experimental Validation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9278495
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9278495
Other Identifiers
ISSN
2314-6133
E-ISSN
2314-6141
DOI
10.1155/2022/7382130
